New Delhi, Dec 5 (PTI) Home-grown FMCG firm Dabur on Friday said it has received an observation letter with “no adverse observations" from the BSE over its Scheme of Amalgamation of Sesa Care.

“We would like to inform you that the Company has received observation letter with ‘no adverse observations’ from BSE Limited (“BSE") on December 4, 2025," Dabur said in a regulatory filing.

An observation letter from the BSE is a formal document issued to a listed company, usually regarding a significant corporate action like a merger, amalgamation, or restructuring, stating the exchange’s review and “no adverse observations" on the proposed scheme, allowing the company to proceed to the next regulatory step.

“The Scheme remains subject to various statutory and regulatory approvals and of the res

See Full Page